|
Clene Inc
CLNN's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Clene Inc 's sales fell
by -19.44 % in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 2344
Major Pharmaceutical Preparations industry recorded
growth of revenues by 9.72 %
Clene Inc net loss increased from $-2 millions, to $-8 millions in III. Quarter 2024,
• More on CLNN's Growth
|
|
Clene Inc realized a net loss in trailing twelve months.
Clene Inc realized cash reduction of $ -4.19 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 60.44.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.28.
• More on CLNN's Valuation
|
|
|
|
|
Clene Inc realized net loss in trailing twelve months.
Clene Inc realized cash outflow of $ -4.19per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 60.44.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.28.
• More on CLNN's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com